ask="N/A"
ask_size="N/A"
average_daily_volume="969023"
bid="53.54"
bid_size="800"
book_value="10.71"
change="+2.74"
change_from_200_day_moving_average="5.94"
change_from_50_day_moving_average="8.09"
change_from_52_week_high="-25.84"
change_From_52_week_low="22.89"
change_in_percent="+5.32%"
close="54.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-5.35"
ex_dividend_date="N/A"
float_shares="71077000"
high="55.15"
high_52_weeks="80.11"
last_trade_date="3/15/2017"
last_trade_price="54.27"
last_trade_size="55205"
last_trade_time="4:00pm"
low="51.35"
low_52_weeks="31.38"
market_capitalization="4.67B"
moving_average_200_day="48.33"
moving_average_50_day="46.18"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.40"
open="51.77"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+12.28%"
percent_change_from_50_day_moving_average="+17.52%"
percent_change_from_52_week_high="-32.26%"
percent_change_from_52_week_low="+72.94%"
previous_close="51.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.81"
price_per_sales="93.99"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="11.04"
stock_exchange="NMS"
symbol="ALNY"
volume="1296204"
weeks_range_52="31.38 - 80.11"
